- Home
- RMTI vs ABVC Comparison
RMTI vs ABVC Comparison
Compare RMTI & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- ABVC
- Stock Information
- Founded
- RMTI 1994
- ABVC 2015
- Country
- RMTI United States
- ABVC United States
- Employees
- RMTI N/A
- ABVC N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- RMTI Health Care
- ABVC Health Care
- Exchange
- RMTI Nasdaq
- ABVC Nasdaq
- Market Cap
- RMTI 58.9M
- ABVC 52.1M
- IPO Year
- RMTI 1998
- ABVC N/A
- Fundamental
- Price
- RMTI $1.63
- ABVC $2.82
- Analyst Decision
- RMTI Strong Buy
- ABVC
- Analyst Count
- RMTI 2
- ABVC 0
- Target Price
- RMTI $4.00
- ABVC N/A
- AVG Volume (30 Days)
- RMTI 3.0M
- ABVC 106.1K
- Earning Date
- RMTI 11-11-2025
- ABVC 11-13-2025
- Dividend Yield
- RMTI N/A
- ABVC N/A
- EPS Growth
- RMTI N/A
- ABVC N/A
- EPS
- RMTI N/A
- ABVC N/A
- Revenue
- RMTI $87,966,000.00
- ABVC $391,242.00
- Revenue This Year
- RMTI N/A
- ABVC $735.18
- Revenue Next Year
- RMTI $10.99
- ABVC N/A
- P/E Ratio
- RMTI N/A
- ABVC N/A
- Revenue Growth
- RMTI N/A
- ABVC 186.84
- 52 Week Low
- RMTI $0.78
- ABVC $0.40
- 52 Week High
- RMTI $5.15
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- RMTI 59.87
- ABVC 48.10
- Support Level
- RMTI $1.60
- ABVC $2.64
- Resistance Level
- RMTI $1.85
- ABVC $3.14
- Average True Range (ATR)
- RMTI 0.21
- ABVC 0.16
- MACD
- RMTI -0.01
- ABVC -0.00
- Stochastic Oscillator
- RMTI 50.55
- ABVC 46.10
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.